FDA Drug Shortages

THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Rocuronium Bromide Injection
Status: Currently in Shortage
»Date first posted: 02/15/2023
»Therapeutic Categories: Anesthesia

Expand all

Almaject (New 02/27/2023)

Company Contact Information:
866-770-3024

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 50 mg/5 mL (NDC 72611-756-01)	Available	Gland is the application holder and Almaject is the distributor/labeler
Injection, 100 mg/10 mL (NDC 72611-757-01)	Unavailable	Gland is the application holder and Almaject is the distributor/labeler

Baxter Healthcare (Revised 08/23/2023)

Company Contact Information:
888-229-0001

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)	Available	Tamarang is the application holder and Baxter is the distributor/labeler
Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)	Limited supply; Recovery Q1 2024	Tamarang is the application holder and Baxter is the distributor/labeler

Hikma Pharmaceuticals USA Inc. (New 02/24/2023)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)	This presentation is temporarily on backorder.	Additional lots will be available in the March 2023 timeframe. Product will be made available as it is released.	Demand increase for the drug
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)	This presentation is temporarily on backorder.	Additional lots will be available in the March - April 2023 timeframe. Product will be made available as it is released.	Demand increase for the drug

Meitheal Pharmaceuticals, Inc. (New 06/29/2023)

Company Contact Information:
844-824-8426

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)	Available
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)	Available

Mylan Institutional, a Viatris Company (Reverified 09/12/2023)

Company Contact Information:
800-796-9526

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)	Available
Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)	Available